The neural circuits and molecular mechanisms underlying fear dysregulation in posttraumatic stress disorder

Front Neurosci. 2023 Dec 5:17:1281401. doi: 10.3389/fnins.2023.1281401. eCollection 2023.

Abstract

Post-traumatic stress disorder (PTSD) is a stress-associated complex and debilitating psychiatric disorder due to an imbalance of neurotransmitters in response to traumatic events or fear. PTSD is characterized by re-experiencing, avoidance behavior, hyperarousal, negative emotions, insomnia, personality changes, and memory problems following exposure to severe trauma. However, the biological mechanisms and symptomatology underlying this disorder are still largely unknown or poorly understood. Considerable evidence shows that PTSD results from a dysfunction in highly conserved brain systems involved in regulating stress, anxiety, fear, and reward circuitry. This review provides a contemporary update about PTSD, including new data from the clinical and preclinical literature on stress, PTSD, and fear memory consolidation and extinction processes. First, we present an overview of well-established laboratory models of PTSD and discuss their clinical translational value for finding various treatments for PTSD. We then highlight the research progress on the neural circuits of fear and extinction-related behavior, including the prefrontal cortex, hippocampus, and amygdala. We further describe different molecular mechanisms, including GABAergic, glutamatergic, cholinergic, and neurotropic signaling, responsible for the structural and functional changes during fear acquisition and fear extinction processes in PTSD.

Keywords: amygdala; hippocampus; neural circuitry; posttraumatic stress disorder; prefrontal cortex.

Publication types

  • Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from the National Natural Science Foundation of China (32250410298), the Science and Technology Planning Project of Shenzhen Municipality (KCXFZ20211020164543007 and 20210617155253001), the Foundation of Development and Reform Commission of Shenzhen Municipality (XMHT20220104028), the Guangdong Basic and Applied Basic Research Foundation (2021A1515012141) and the Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties (SZGSP013).